Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Benjamin

Showing results (101-110 of 2,042) with videos related to

Pageof 205
Sort By:
Nature|March 23, 2018
A global observatory for gene editingSheila Jasanoff, J Benjamin Hurlbut
Transfusion|January 5, 2002
Transfusion medicine illustrated. Erythrophagocytosis after an ABO-mismatched stem cell transplantA Zubair, R J Benjamin
Nature|April 3, 1986
Induction of tolerance by monoclonal antibody therapyR J Benjamin, H Waldmann
Cancers|November 27, 2021
Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder CancerDavid J Benjamin, Yung Lyou
The Oncologist|September 8, 2023
Reevaluating Adjuvant Capecitabine for Resected Biliary Tract CancerDavid J Benjamin, Vinay Prasad
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2022
Freeing the Competition: Will Aumolertinib (AENEAS) Have a Fighting Chance Against Osimertinib (FLAURA)?David J Benjamin, Misako Nagasaka
Orthopedics|May 15, 2014
Irreducible lateral dislocation of the patella: a case reportJ Benjamin, E C Percy
Journal of Clinical Pathology|June 1, 1980
A human strain of Campylobacter fetus subsp. intestinalis grown at 42 degrees CM B Skirrow, J Benjamin
European Journal of Cancer (Oxford, England : 1990)|October 5, 2024
Inadequate staging and excessive surveillance imaging: Evaluating the magnitude of benefit of targeted therapies in lung cancerDavid J Benjamin, Vinay Prasad
Nature Reviews. Clinical Oncology|May 31, 2023
The FDA's latest draft guidance on accelerated approvals - one step forward, two steps back?David J Benjamin, Mark P Lythgoe
Pageof 205

Showing results (101-110 of 2,042) with videos related to

Sort By:
Pageof 205
Nature|March 23, 2018
A global observatory for gene editingSheila Jasanoff, J Benjamin Hurlbut
Transfusion|January 5, 2002
Transfusion medicine illustrated. Erythrophagocytosis after an ABO-mismatched stem cell transplantA Zubair, R J Benjamin
Nature|April 3, 1986
Induction of tolerance by monoclonal antibody therapyR J Benjamin, H Waldmann
Cancers|November 27, 2021
Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder CancerDavid J Benjamin, Yung Lyou
The Oncologist|September 8, 2023
Reevaluating Adjuvant Capecitabine for Resected Biliary Tract CancerDavid J Benjamin, Vinay Prasad
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2022
Freeing the Competition: Will Aumolertinib (AENEAS) Have a Fighting Chance Against Osimertinib (FLAURA)?David J Benjamin, Misako Nagasaka
Orthopedics|May 15, 2014
Irreducible lateral dislocation of the patella: a case reportJ Benjamin, E C Percy
Journal of Clinical Pathology|June 1, 1980
A human strain of Campylobacter fetus subsp. intestinalis grown at 42 degrees CM B Skirrow, J Benjamin
European Journal of Cancer (Oxford, England : 1990)|October 5, 2024
Inadequate staging and excessive surveillance imaging: Evaluating the magnitude of benefit of targeted therapies in lung cancerDavid J Benjamin, Vinay Prasad
Nature Reviews. Clinical Oncology|May 31, 2023
The FDA's latest draft guidance on accelerated approvals - one step forward, two steps back?David J Benjamin, Mark P Lythgoe
Pageof 205